SMTL ID : 1d8t.1 (1 other biounit)

CRYSTAL STRUCTURE OF ELONGATION FACTOR, TU (EF-TU-MGGDP) COMPLEXED WITH GE2270A, A THIAZOLYL PEPTIDE ANTIBIOTIC

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.35 Å

Oligo State

hetero-1-1-mer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 3 residues within 4Å: Chain A: T.25, D.50 Ligands: GDP.2 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:T.25, H2O.1, H2O.3, H2O.3, H2O.9

1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)

GDP.2: 17 residues within 4Å: Chain A: H.19, V.20, D.21, H.22, G.23, K.24, T.25, T.26, F.46, N.135, K.136, D.138, M.139, S.173, A.174, L.175 Ligands: MG.1 23 PLIP interactions: 23 interactions with chain A Hydrogen bonds: A:D.21, A:H.22, A:G.23, A:K.24, A:T.25, A:T.26, A:T.26, A:N.135, A:K.136, A:K.136, A:A.174, A:L.175 Water bridges: A:D.21, A:D.21, A:D.21, A:D.21, A:T.25, A:T.25, A:T.26, A:C.81, A:K.136 Salt bridges: A:K.24, A:D.138

19 x ACT: ACETATE ION(Non-functional Binders)

ACT.3: 5 residues within 4Å: Chain A: R.154, T.167, P.168, I.169 Ligands: ACT.13 Ligand excluded by PLIP ACT.4: 4 residues within 4Å: Chain A: R.123, Q.124, D.370, A.389 Ligand excluded by PLIP ACT.5: 2 residues within 4Å: Chain A: R.154, D.165 Ligand excluded by PLIP ACT.6: 4 residues within 4Å: Chain A: R.116, E.152, E.155, Q.159 Ligand excluded by PLIP ACT.7: 3 residues within 4Å: Chain A: T.302, L.362, I.363 Ligand excluded by PLIP ACT.8: 4 residues within 4Å: Chain A: M.98, V.125, V.127, R.373 Ligand excluded by PLIP ACT.9: 4 residues within 4Å: Chain A: P.111, M.112, P.113, R.116 Ligand excluded by PLIP ACT.10: 5 residues within 4Å: Chain A: C.137, R.171, W.184, K.187 Ligands: ACT.17 Ligand excluded by PLIP ACT.11: 2 residues within 4Å: Chain A: I.247, E.287 Ligand excluded by PLIP ACT.12: 4 residues within 4Å: Chain A: H.301, V.391, L.392, G.393 Ligand excluded by PLIP ACT.13: 6 residues within 4Å: Chain A: I.169, V.170, R.171, K.187, E.190 Ligands: ACT.3 Ligand excluded by PLIP ACT.14: 2 residues within 4Å: Chain A: E.3, E.6 Ligand excluded by PLIP ACT.15: 2 residues within 4Å: Chain A: D.50, P.82 Ligand excluded by PLIP ACT.16: 5 residues within 4Å: Chain A: R.44, P.53, T.64, S.65, H.66 Ligand excluded by PLIP ACT.17: 7 residues within 4Å: Chain A: V.140, D.141, D.142, E.143, L.146, R.171 Ligands: ACT.10 Ligand excluded by PLIP ACT.18: 3 residues within 4Å: Chain A: Y.129, S.197, Y.198 Ligand excluded by PLIP ACT.19: 6 residues within 4Å: Chain A: H.84, A.85, V.88, Y.309, G.353, N.355 Ligand excluded by PLIP ACT.20: 4 residues within 4Å: Chain A: S.219, I.220, S.221, G.224 Ligand excluded by PLIP ACT.21: 7 residues within 4Å: Chain A: L.35, Y.39, T.71, L.189, A.192, G.193, D.196 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Heffron, S.E. et al., Structure of an EF-TU Complex with a Thiazolyl Peptide Antibiotic Determined at 2.35 A Resolution: Atomic Basis for Ge2270A Inhibition of EF-TU. Biochemistry (2000)

Release Date

2000-10-25

Peptides

ELONGATION FACTOR TU: A
THIOCILLIN GE2270: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

ELONGATION FACTOR TU

THIOCILLIN GE2270

Related Entries With Identical Sequence